Red/NIR‐I‐Fluorescence Carbon Dots Based on Rhein with Active Oxygen Scavenging and Colitis Targeting for UC Therapeutics

Author:

Xia Jiashan1,Wang Jiayu2,Liu Fengyuan1,Chen Zhiqiong1,Chen Changmei1,Cheng Xiangshu1,Chao Yu134,Wang Yue5,Deng Tao134ORCID

Affiliation:

1. College of Pharmacy Chongqing Medical University Chongqing 400016 P. R. China

2. Department of Pharmacy Chongqing Health Center for Women and Children Women and Children's Hospital of Chongqing Medical University Chongqing 401147 P. R. China

3. Chongqing Pharmacodynamic Evaluation Engineering Technology Research Center Chongqing 400016 P. R. China

4. Chongqing Key Laboratory for Pharmaceutical Metabolism Research Chongqing 400016 P. R. China

5. NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases The First Affiliated Hospital of Chongqing Medical University Chongqing 400016 P. R. China

Abstract

AbstractUlcerative colitis (UC) is a chronic inflammatory disease with uncontrolled inflammation and demage to the intestinal barrier. Rhein, a bioactive compound in traditional Chinese medicine, has anti‐inflammatory and intestinal repair effect. However, their clinical application is limited by their hydrophobicity and poor bioavailability. L‐arginine, as a complement to NO, has synergistic and attenuating effects. In this paper, red/NIR‐I fluorescent carbon dots based on rhein and doped with L‐arginine (RA‐CDs), which are synthesized by a hydrothermal process without any organic solvents, are reported. RA‐CDs preserve a portion of the functional group of the active precursor, increase rhein solubility, and emit red/NIR‐I light for biological imaging. In vitro experiments show that RA‐CDs scavenge excessive reactive oxygen species (ROS), protect cells from oxidative stress, and enable the fluorescence imaging of inflamed colons. In a DSS‐induced UC mouse model, both delayed and prophylactic treatment with RA‐CDs via intraperitoneal and tail vein injections alleviate UC severity by reducing intestinal inflammation and restoring the intestinal barrier. This study highlights a novel strategy for treating and imaging UC with poorly soluble small‐molecule drugs.

Funder

China Postdoctoral Science Foundation

Chongqing Postdoctoral Science Foundation

Natural Science Foundation of Chongqing Municipality

Publisher

Wiley

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3